Albemarle (ALB) 8-K Regulation FD Disclosure

Lithium Day

A deep dive into Albemarle’s lithium business

September 2015

Exhibit 99.1

Today’s Participants

2

Scott Tozier

Senior Vice President &

Chief Financial Officer

Albemarle Corporate Overview

Luke Kissam

President & Chief Executive Officer

Performance Chemicals Overview

David Klanecky

Vice President, Energy Solutions

Energy Storage Applications –

Market Dynamic & Growth Potential

Raphael Crawford

Vice President,

Synthesis & Polymers Solutions

Lithium Organometallics –

An Important Specialty Business

John Mitchell

Vice President, Performance Materials

Albemarle’s Global Position in Lithium

Some

of

the

information

presented

in

this

presentation

and

the

conference

call

and

discussions

that

follow,

including,

without

limitation,

statements

with

respect

to

the

transaction

with

Rockwood

and

the

anticipated

consequences

and

benefits

of

the

transaction,

product

development,

changes

in

productivity,

market

trends,

price,

expected

growth

and

earnings,

input

costs,

surcharges,

tax

rates,

stock

repurchases,

dividends,

cash

flow

generation,

costs

and

cost

synergies,

portfolio

diversification,

economic

trends,

outlook

and

all

other

information

relating

to

matters

that

are

not

historical

facts

may

constitute

forward-looking

statements

within

the

meaning

of

the

Private

Securities

Litigation

Reform

Act

of

1995.

There

can

be

no

assurance

that

actual

results

will

not

differ

materially.

Factors

that

could

cause

actual

results

to

differ

materially

include,

without

limitation:

changes

in

economic

and

business

conditions;

changes

in

financial

and

operating

performance

of

our

major

customers

and

industries

and

markets

served

by

us;

the

timing

of

orders

received

from

customers;

the

gain

or

loss

of

significant

customers;

competition

from

other

manufacturers;

changes

in

the

demand

for

our

products;

limitations

or

prohibitions

on

the

manufacture

and

sale

of

our

products;

availability

of

raw

materials;

changes

in

the

cost

of

raw

materials

and

energy;

changes

in

our

markets

in

general;

fluctuations

in

foreign

currencies;

changes

in

laws

and

government

regulation

impacting

our

operations

or

our

products;

the

occurrence

of

claims

or

litigation;

the

occurrence

of

natural

disasters;

the

inability

to

maintain

current

levels

of

product

or

premises

liability

insurance

or

the

denial

of

such

coverage;

political

unrest

affecting

the

global

economy;

political

instability

affecting

our

manufacturing

operations

or

joint

ventures;

changes

in

accounting

standards;

the

inability

to

achieve

results

from

our

global

manufacturing

cost

reduction

initiatives

as

well

as

our

ongoing

continuous

improvement

and

rationalization

programs;

changes

in

the

jurisdictional

mix

of

our

earnings

and

changes

in

tax

laws

and

rates;

changes

in

monetary

policies,

inflation

or

interest

rates;

volatility

and

substantial

uncertainties

in

the

debt

and

equity

markets;

technology

or

intellectual

property

infringement;

decisions

we

may

make

in

the

future;

the

ability

to

successfully

operate

and

integrate

Rockwood’s

operations

and

realize

estimated

synergies;

and

the

other

factors

detailed

from

time

to

time

in

the

reports

we

file

with

the

SEC,

including

those

described

under

"Risk

Factors"

in

the

joint

proxy

statement

/

prospectus

we

filed

in

connection

with

the

transaction

with

Rockwood,

and

in

our

Annual

Report

on

Form

10-K

and

our

Quarterly

Reports

on

Form

10-Q.

These

forward-looking

statements

speak

only

as

of

the

date

of

this

presentation.

We

assume

no

obligation

to

provide

any

revisions

to

any

forward-looking

statements

should

circumstances

change,

except

as

otherwise

required

by

securities

and

other

applicable

laws.

Forward-looking Statements

3

It

should

be

noted

that

adjusted

net

income

attributable

to

Albemarle

Corporation

(“adjusted

earnings”),

adjusted

diluted

earnings

per

share,

adjusted

effective

income

tax

rates,

segment

operating

profit,

segment

income,

EBITDA,

adjusted

EBITDA,

adjusted

EBITDA

by

operating

segment,

EBITDA

margin

and

adjusted

EBITDA

margin

are

financial

measures

that

are

not

required

by,

or

presented

in

accordance

with,

accounting

principles

generally

accepted

in

the

United

States,

or

GAAP.

These

measures

are

presented

here

to

provide

additional

useful

measurements

to

review

our

operations,

provide

transparency

to

investors

and

enable

period-to-period

comparability

of

financial

performance.

A

description

of

these

and

other

non-GAAP

financial

measures

that

we

use

to

evaluate

our

operations

and

financial

performance,

and

reconciliation

of

these

non-GAAP

financial

measures

to

the

most

directly

comparable

financial

measures

calculated

and

reported

in

accordance

with

GAAP,

can

be

found

in

the

Appendix

to

this

presentation,

which

is

posted

in

the

Investors

section

of

our

website

at

www.albemarle.com,

under

“Non-GAAP

Reconciliations”

under

“Financials.”

4

Non-GAAP Financial Measures

Corporate Overview

Scott Tozier

Senior Vice President & Chief Financial Officer

6

Leadership Across Attractive Growth Segments

#2

$816

$193

24%

Chemetall Surface

Treatment

Global

Ranking

TTM 2Q 2015

Sales

Adj. EBITDA

(1)

% Margin

(1)

Key

Competitors

Performance Chemicals

#1

$483

$200

41%

Growth

2.0x –

3.0x

GDP

Refining Solutions

#1/2

1.0x –

2.0x

GDP

#1/2

1.0x –

1.5x

GDP

1.0x –

2.0x

GDP

Characteristics

•

Mineral extraction and processing businesses

•

Low cost position on global cost curve

•

Vertically integrated

•

High demand growth

•

Technology and applications driven

•

Critical customer service

•

Ability to differentiate offering

•

Strong free cash flow

$797

$219

28%

$326

$93

29%

Source: Company information.

(1)

Non-GAAP measure. See non-GAAP reconciliations in Appendix.

(2)

PCS segment also includes Curatives. Note: PCS is considered by management estimates to have leading positions in organometallics, MAO, and custom single site

catalysts/metallocenes

Lithium

Bromine

PCS

2

#1/2

$824

$238

29%

~1.0x

GDP

2015 Commitments

Synergies of $50M in 2015 & $100M in 2016 with costs to

achieve of $250M -

$275M (including acquisition costs)

Divest non-core assets

Refinance Rockwood 2020s

Adjusted Free Cash Flow* of $450-$550M

Adjusted EPS* of $3.65 to $4.05

7

*Non-GAAP measure. See non-GAAP reconciliations in Appendix.

Synergies Exceeding Expectations –

Approaching $120M in 2016

8

•

Corporate Costs

»

Estimated savings ~$45M in 2016

»

Actions already taken will result in ~$35M in 2016

•

Executive consolidation

•

Insurance policy renegotiations

•

Assets & Manufacturing

»

Estimated savings ~$30M in 2016

»

Actions already taken will result in ~$10M+ in 2016

•

Site Rationalizations: Princeton and partial New Johnsonville closures

•

Raw material contracts

•

Continued review of global footprint

•

Non-Raw Material Sourcing

»

Estimated savings ~$20M in 2016

»

Actions already taken will result in ~$5M+ in 2016

•

Entered into and executed specific logistic contracts and processes

•

Global network optimization project

•

Global consolidation of software and hardware licenses

•

Contract renegotiations for packaging and plant supplies

•

Organization Structure

»

Estimated savings ~$25M in 2016

»

Actions already taken will result in ~$15M+ in 2016

•

Additional opportunities to combine business functions

•

Back office consolidations

2015 Sources

Corporate

Costs

Assets &

Manufacturing

Non-RM

Sourcing

Org. Structure

2016 Sources

Corporate Costs

Assets &

Manufacturing

Non-RM

Sourcing

Org. Structure

•

Expect to reach target Net-Debt-to-Adjusted EBITDA

leverage of ~2.5x between Q3 2017 and year end 2018

•

FCF Key Assumptions and Impacts:

»

Tax rate of ~27%

»

Interest

Expense

~$90M,

down

from

~$130M

on

refinancing of Rockwood 2020s

»

CAPEX in the range of 4-6% of revenue plus LiOH2

plant

»

One-time acquisition and integration costs of $50 -

$75M and one-time tax payment ~$50M in 2016

»

No operating income from divested businesses;

proceeds go to deleveraging

»

Opportunity for working capital reduction

•

Raised

dividend

by

5%

in

Q1

2015

–

21

st

straight

dividend increase

»

Expect similar increases until target reached

1

Non-GAAP measure. See Non-GAAP reconciliations in Appendix.

2

Net-Debt-to-Adjusted EBITDA ratio is based on the bank covenant definition.

Free

Cash

Flow

1

$600M -

$900M

Net-Debt-to-Adj.

EBITDA

2

$550M -

$650M

$450M -

$550M

Working Capital Upside Opportunity to

Further Improve FCF

~$50 Acq. Taxes

~$50-75 Acq. Costs

~$100 Acq. Taxes

~$200 Acq. Costs

$150 -

$250

FCF

$450 -

$550

FCF

2015 Adjusted FCF

Outlook

2016 FCF Outlook

3 -

5 Year Adjusted FCF

Outlook

2015

2016

2017

2018

Bull

Bear

Target

9

Clear Path to Deleverage with Strong Free Cash Flow

Divest Non-core Assets to Focus on Core Growth

10

Allows for focus and resources on our core businesses to accelerate growth

•

The three businesses in aggregate

generated  revenue of about $550M and

adjusted EBITDA of about  $100M for 2014

•

All are solid businesses, but do not factor

into long-term growth plans

•

Goal is to complete the divestitures by end

of 2015

•

Proceeds from the divestitures to be used

for debt reduction

•

Minerals and Metal Sulfide have performed

in line with our expectations from the

beginning of the year, but Fine Chemistry

Services is down significantly vs. 2014

Minerals

Fine

Chemistry

Services

Metal

Sulfide

•

Robust & differentiated portfolio of mineral flame

retardants

–

products

used

in

wire

and

cable,

electronic

and electrical components and non-FRs product used

in building materials, mass transportation, paints &

varnishes and  paper with organic binder

»

Revenue:

~$250M

»

EBITDA Margins:

~10%

•

Custom synthesis manufacturing of pharma products,

agricultural actives and intermediates, agrichemicals,

oil base lubricants and specialty chemicals industries

»

Revenue: ~$200M

»

EBITDA Margins: upper 20%

•

Full-service supplier of both natural and synthetic metal

sulfide. Metal sulfides have applications in the friction,

abrasive, lubricant and other industries

»

Revenue: ~$100M

»

EBITDA Margins: high teens

Refinance Rockwood 2020s

11

Existing

and

pro

forma

capitalization

($

millions)

Actual

Jun-15

Pro Forma

Jun-15

% of cap

xEBITDA

Cash and cash equivalents

$207

$164

Existing $1,000mm R/C

--

--

New $300

million 364-dayTerm Loan A

--

300

New $950 million

5-year Term Loan A

--

950

Commercial

paper notes

418

418

Rockwood senior notes

1,250

--

Other

senior

notes

2,157

2,157

Other

debt

136

136

Total

Debt

$3,961

$3,961

41%

3.7x

Market equity (as

of 8/14/15)

$5,735

$5,735

59%

Total Capitalization

$9,695

$9,695

100%

Existing and pro forma capitalization ($ millions)

Sources

Uses

Cash

$43

Refinance

existing

4.625%

senior

notes

$1,250

New 364-day

Term Loan A

300

Call premium

$43

New

5-year Term Loan A

950

Total

$1,293

Total

$1,293

Note: excludes fees and expenses

Reaffirming Full Year 2015 Guidance

12

Division

Initial

Outlook

Updated

Outlook

Business Environment

Refining

Solutions

Heavy Oil Upgrading

•

Volume

growth

on

increased transportation fuel demand and new

business. Secured 100% of business subject to commercial trials in

1H of year with multi-year contracts

Clean Fuel

Technologies

•

Delayed

change outs and cost control measures by refiners as well

as weaker mix and fewer first fills

•

Euro-based competitor pricing pressure

Performance

Chemicals

Bromine

•

Drilling

completion

fluids

volumes

for

1

st

half

held

up

okay

in

GOM,

but

weak

rest

of

world.

Expect

decline

in

2

nd

half

•

Net benefit expected from previously announced 30% price

increase

Lithium

•

Meaningful growth driven by combination of full year Talison

earnings, strong demand and improved pricing for battery grade

lithium

PCS / Curatives

•

Outlook for polyolefins

remain strong with solid growth and

increased demand expected

•

Competitive

environment and demand for Curatives leading to

further improvement for full year

Surface

Treatment

Surface

Treatment

•

Solid underlying market growth in most segments, product mix

improvement, positive price improvement and acquisition benefits

Total

Company

•

YoY

FX

impact

~$250M

on

Sales

and

$50

–

$60M

on

EBITDA

•

Sales $3.6b to $3.8b –

flat to up 3% -

ex FX

•

Raising

Adjusted

EBITDA

to

$940M

to

$1,000M

–

up

3-11%

ex

FX

•

Margins

increasing to 24%-26% excluding Q1 FX gain

•

Free Cash Flow $150M to $250M

•

Reaffirming Adjusted EPS of $3.65 to $4.05 despite headwind of

$0.03 –

$0.05 due to

higher annual tax rate and depreciation

Better

than 2014 

Worse

than 2014

Similar

to 2014

On Track to Meet our 2015 Commitments

Synergies of $50MM in 2015 & $100M in 2016 with costs to

achieve of $250M -

$275M (including acquisition costs)

Divest non-core assets

Refinance Rockwood 2020s

Adjusted Free Cash Flow of $450-$550M

Adjusted EPS of $3.65 to $4.05

13

Performance Chemicals

Luke Kissam

President & Chief Executive Officer

Performance Chemicals Growing in All Three Businesses

Segment

Adjusted EBITDA Growth

Current Outlook

Lithium

Driven by volume growth in battery

grade products, increased pricing

in battery grade and other lithium

products and the impact of the

Talison JV

Bromine

Improved pricing across the

portfolio and volume improvement

in our flame retardants business

PCS / Curatives

Business

is

stable

with

recent

spikes driven by strong curatives

demand and pricing and one-time

orders

15

-20.0%

-15.0%

-10.0%

-5.0%

0.0%

5.0%

10.0%

15.0%

20.0%

25.0%

30.0%

Q1 '14

Q2 '14

Q3 '14

Q4 '14

Q1 '15

Q2 '15

-40.0%

-30.0%

-20.0%

-10.0%

0.0%

10.0%

20.0%

30.0%

40.0%

Q1 '14

Q2 '14

Q3 '14

Q4 '14

Q1 '15

Q2 '15

-40.0%

-20.0%

0.0%

20.0%

40.0%

60.0%

80.0%

Q1 '14

Q2 '14

Q3 '14

Q4 '14

Q1 '15

Q2 '15

Performance Chemicals Leadership Team

With over 275

years of combined experience, our leadership team remains focused and will

continue to drive the same growth and financial performance we have come to expect

16

Dr. Ron Zumstein

Manufacturing

Dr. Dave Clary

Research &

Technology

Dr. Marcus Brune

Finance

Jake Wilson

Legal

Susan Shepherd

HR

Functional Excellence

28yrs

30yrs

24yrs

13yrs

29yrs

Ahmad Khalifeh

JBC GM

Stephen Elgueta

Chile GM

Key

Country Leaders

36yrs

25yrs

John Mitchell

Performance

Materials

Dr. David Klanecky

Energy Solutions

Troy DeSoto

Fire Safety Solutions

& Curatives

Raphael Crawford

Synthesis & Polymer

Solutions

Business

Heads

24yrs

22yrs

26yrs

18yrs

Lithium Vision and Strategy

Our Vision

To extend our position as the leading lithium company in the world

Customers / Markets

•

Maintain share in historical core markets

•

Capture 50% of incremental growth in energy storage market

Supply

•

Security of supply of low-cost, high quality Li resources

•

Maintain world-class supply chain and process technologies

Technology

•

Strong focus on innovation and cooperation with our customers to

develop next-generation Li based materials

•

Process technology breakthroughs for the production of high-quality /

low-cost Li compounds

Our Strategy

17

Lithium –

Historical Financial Performance

Adjusted EBITDA

•

Lithium continues to exceed expectations driven by volume growth in battery grade products

•

Talison JV performance better than expected on both volumes and margins

•

Overall pricing up 3% in Q2 2015 before FX with battery grade products up 5%

2015 Performance Drivers

Net Sales

$200

$250

$300

$350

$400

$450

$500

2009

2010

2011

2012

2013

2014

2015**

30%

32%

34%

36%

38%

40%

42%

44%

$100

$125

$150

$175

$200

2009

2010

2011

2012

2013

2014

2015*

Adj. EBITDA

% Margin

$M

$M

18

* LTM from Q2 2015

Mega-Trends Driving Lithium Growth

19

•

New active pharmaceutical ingredients

•

New agro ingredients & resistance

•

Reduction of greenhouse gas

•

Miniaturization of electronic devices

•

Extended range of electronic devices

•

High-power electronic devices

•

Exponential growth of transportation

•

Renewable energy concepts

•

Smart grid & energy storage

•

Less energy and water

•

Fewer chemicals & simpler processes

Lithium creates sustainable future technologies

Potential Lithium Demand Delivers Significant Upside

20

Source: Rockwood Lithium estimates and market surveys from BCG, Bloomberg, Avicenne, Roland Berger, Pike Research, Frauenhofer IST, Deutsche Bank Research, McKinsey,

CTI, Anderman, JD Powers

Albemarle expects to capture 50% of lithium growth

Breadth of Albemarle Product Portfolio Leads to #1 Overall Position

21

Application

2014

Market

Size

Growth

Rate

Products

Glass/Ceramics

46KT

GDP

•

Spodumene

•

Li

2

CO

3

Greases / Lubricants

18KT

GDP

•

LiOH

Chemical Synthesis

11KT

GDP

•

Li Organometallics fed by Li

Metal LiCl

Portable

Electronics

&

Other Handhelds

48KT

16% 

(Base

Case)

•

BG  Li

2

CO

3

•

BG LiOH

•

BG Li Metal

•

BG Electrolyte Salts

•

BG LiCl

•

BG Alloys

•

BG Specialty Compounds

Hybrids

Battery Electric

Vehicle (BEV)

Grid and Other Power

Storage

Applications

Total Global LCE Market:  160kT  (2014)

Source: Internal

Core Messages

22

1

Albemarle is the leader in lithium, one of the highest growth markets in the

specialty chemicals industry

2

Our unique

natural resource position, derivatization capabilities and

technology leadership allow Albemarle to execute its growth strategy

3

We can sustain the Albemarle advantage because our unique position is

difficult to replicate  and has taken more than 100 years to establish

Energy Storage Applications –

Market Dynamic & Growth Potential

David Klanecky

Vice President, Energy Solutions

Without Li-Ion Batteries, There Would be No…

24

1992

1st Mass

Produced Li-

Ion Battery

Cell

2007

iPhone

debuts

Smartphones

|  Tablets

|   Laptops   |   xEV’s

|   Wearables

2003

Cell phones

become

mainstream

Without Li-Ion Batteries, there would be no…

Apple

| Samsung

| Tesla

...as we know them today.

2008

Tesla

debuts its

Roadster

In 5 years, Li-Ion batteries went from a

niche end-use to the #1 consuming market

for Lithium with explosive growth from

consumer electronics

and expansion into

transportation, grid and consumer

devices

2015 & Beyond

Power tools &

wearables

create

additional

demand for Li-ion

batteries

Consumer Electronics

Previously, there was one

major industry investing in

batteries….

8 -

10% CAGR

Mass Uptake in Battery Markets

25

Transportation

20 -

30% CAGR

Energy Storage

>30% CAGR

Replicating Success

“We are at a dawn of a new era with ‘unprecedented technological

& regulatory change’ set to come in the next 5 years…”

(Deutsche Bank, Dec 2014)

Consumer Devices

>15% CAGR

Source for projected CAGRs:  Signumbox, 2015

Li-Ion Battery Market Has Yet to Reach Maturity and

Continues to Find New Applications

26

Lithium Requirements Across End-use Applications

27

Example: 1,200 million smartphones sold in 2014… each containing 7g Li (LCE) basis… equating to 8,400 MT Li, LCE Basis

2014 Sales

(M Units)

Li Content per Unit

(LCE Basis)

2014 Total Li Content

(LCE Basis)

Projected CAGR

(2014 –

2024)

Smartphone

1,200

5 –

7 grams

8,400 MT

8-10%

Tablet

260

20 –

30

grams

7,800 MT

Notebook

170

35 –

45 grams

7,650 MT

Power Tools

65

40 –

60 grams

3,900 MT

>15%

HEV

1.8

5 kilograms

9,000 MT

20-30%

PHEV & BEV

0.3

40 –

80 kilograms

18,000 MT

Stationary

[650 MWh

Installed]

1.5 MT

1,000 MT

>30%

Source: Signumbox, 2015

0

20,000

40,000

60,000

80,000

100,000

120,000

140,000

2010

2015

0

10,000

20,000

30,000

40,000

50,000

60,000

70,000

2010

2015

0

200,000

400,000

600,000

800,000

1,000,000

1,200,000

1,400,000

2010

2015

0

5

10

15

20

25

2010

2015

PHEV

20%

CAGR

PHEV

86%

CAGR

EV

46%

CAGR

Transportation Contributing to Li-Ion Battery Growth

28

Electric

Vehicle

Sales

(US)

–

All

OEMs

Cost of Li-Ion batteries has

declined 14% per year over

the last 15 years

Battery Type

Battery Costs

1,800

1,600

1,400

1,200

1,000

800

600

400

200

2005

2010

2015

2020

2030

2025

HEV

10%

CAGR

New

Model

Launches

(US)

–

All

OEMs

Source: Christophe Pillot, Avicenne Report 2015

0

5

10

15

20

25

2010

2015

EV

38%

CAGR

0

10

20

30

40

50

60

70

2010

2015

HEV

12%

CAGR

Nissan

Tesla

GM

Ford

Toyota

Other

Sources: Lux Research & US DOE Alternative Fuels Data Center, Accessed 3Q, 2015

Nissan

Tesla

GM

Ford

Toyota

Other

Source: Nature Climate Change, 2015

Sources: Lux Research & US DOE Alternative Fuels Data Center, Accessed 3Q, 2015

Consumer Electronics & Devices Contributing to Li-Ion

Battery Growth

29

•

7.7

billion mobile phones/tablets in use

•

1

smartphone for every 4.5

people on the

planet

•

Average person spends 4

hours/day on their

smartphone

•

191

billion e-mails are sent/received each day

•

140

million mobile search queries/day

seamless

communications on control over a range of other IoT

products

0

20000

40000

60000

80000

100000

2000

2005

2010

2013

2015

2020

2025

Others

Power Tools

Household

Toys

MPS

Video Games

Digital Camera

Camcorders

Cordless Phones

Tablets

Portable PCs

Cellular Phones

Consumer Electronics & Devices

LIB Market, by Application

MWh

Source: Bloomberg, Accessed Q3 2015

0

5

10

15

20

25

2013

2014

2015f

2020f

Automotive

Consumer

Generic business

Vertical business

Billions

Internet of Things (IoT)

Units Installed

Source: AT Kearney, Accessed Q3 2015

Consumer

Connectivity

Renewable Energy Storage Contributing to Li-Ion Battery

Growth

30

Stationary Energy Storage

Revenues by Technology

$B

Energy storage unlocks value in existing assets by increasing low rates of utilization

Source; Lux Research; June 2014

Over the next 15 years, ~$1.4 trillion of

future

US

infrastructure

will

be

underutilized

without storage

$0.00

$0.50

$1.00

$1.50

$2.00

$2.50

$3.00

2014

2015

2016

2017

2018

2019

2020

All Others

Lithium Ion

Solar: ~17% CAGR

Wind: ~10% CAGR

Renewable

Energy

Growth

(2013

–

2020)

Li-Ion Battery Growth Accelerated with Industry Leaders

31

Transportation

is

Potential

Game

Changer,

but

Renewable

Storage also has High Potential

Consumer Electronics & Devices

•

Slowing demand for laptops and conventional mobile phones are offset by

robust demand growth for smart phones, tablets and wearables, driven by

trend towards higher-capacity batteries

Consumer Electronics & Devices

•

Slowing demand for laptops and conventional mobile phones are offset by

robust demand growth for smart phones, tablets and wearables, driven by

trend towards higher-capacity batteries

Transportation (PHEV/HEV/EV/2-wheelers)

•

Fast-growing market for hybrids and electric vehicles driven by

regulations/targets on CO

2

emissions, falling battery costs, improved

driving range and expanding charging infrastructure, desire for an

enhanced driving experience

•

Auto penetration: 1 -

2%, base case scenario

Transportation (PHEV/HEV/EV/2-wheelers)

•

Fast-growing market for hybrids and electric vehicles driven by

regulations/targets on CO

2

emissions, falling battery costs, improved

driving range and expanding charging infrastructure, desire for an

enhanced driving experience

•

Auto penetration: 1 -

2%, base case scenario

Renewable (Grid storage)

•

Driven by growth in renewable energy and need for resources to provide

system flexibility and balance supply/demand

•

Global installed base of ~1.1 GW Jan. 2015), projected annual installations

reaching up to >15 GW by 2025

Renewable (Grid storage)

•

Driven by growth in renewable energy and need for resources to provide

system flexibility and balance supply/demand

•

Global installed base of ~1.1 GW Jan. 2015), projected annual installations

reaching up to >15 GW by 2025

0

50

100

150

200

250

2014

2019

2024

Battery LCE Long-term 

Demand Outlook

Base case scenario: 16% CAGR

Consumer

Transportation

Renewable

Source: SAI lithium assessment for Albemarle (2015), sector reports, SAI analysis and estimates

KT

32

Strategic Investments to Meet Market Demand

•

Located in La Negra, Chile

•

20kT battery grade lithium carbonate

•

Produces lowest-cost, highest-quality

battery grade material in the industry

•

Commissioning phase

•

Will be the most technologically advanced

mineral conversion plant ever built

•

Up to 50kT battery grade lithium

derivatives –

Li

2

CO

3

and LiOH

•

Fed from the highest quality Spodumene

resource in the world

•

Expected

startup:

2020

33

Battery Grade Li

2

CO

3

Plant

Planned Battery Grade Li Derivative Plant

Lithium Organometallics –

An Important Specialty Business

Raphael Crawford

Vice President, Synthesis & Polymers Solutions

•

Organometallics is a quality business for Albemarle, delivering  growth with great EBITDA

margins

•

We now have expanded sales coverage for major synthetic rubber producers, allowing us

to streamline our sales operations and achieve sales synergy targets

•

Synergies for capacity rationalization are in motion, further improving our industry-leading

low cost position for lithium supply economics and world-scale production

•

We have made significant R&D investments in organometallics research across our

lithium and aluminum businesses, positioning us to continue our leadership in the market

place

The New Albemarle is a Clear Market Leader in Organometallics Chemistry

from the Combination of the Lithium and Aluminum Franchises

New labs in Frankfurt

R&D Center

35

Major producers include:

Synthetic Rubber

36

•

time

•

surface area

•

catalysts

•

temperature

•

pressure

•

agitation

•

concentration

Albemarle’s Lithium Organometallics are Highly Valuable Tools in Organic

Synthesis and Specialty Polymer Production

Lithium organometallic reagents were the perfect match to broaden the Albemarle aluminum, zinc

and magnesium organometallics specialties portfolio

Lithium organometallics are both highly predictable as well as efficient in specific

application uses

Pharma Actives

AgChem Actives

Block Copolymers

Raw Materials &

Intermediates

Li Organometallics

Initiators & Reagents

Population Growth and Rise of Middle Class

•

India and China driving consumerism

•

Production and consumption shift to Asia

Global Healthcare Infrastructure

•

Cost pressure in developing countries;                                    

API manufacturing shift to India/China

•

Changes in synthetic routes

•

Shift from brands to generic

Sustainability

•

Global regulation of tire industry to decrease

CO

2

emission

•

Increased efficiency in agriculture needed

Macro-Drivers

Growing Consumerism as well as Trends in Regulation, Sustainability

and Healthcare Drive End-market Lithium Organometallics Demand

37

Albemarle Lithium Organometallics

•

Play a vital role in solving these

macroeconomic challenges by

enabling:

»

Novel pharmaceutical API development and

agrochemical synthesis

»

Ultra-high performance synthetic rubber

Synthetic Rubbers are a Growing End-use Market for Albemarle’s

Lithium Organometallic Polymer Initiators

Growing global population and middle class drives higher consumption of rubber goods:

•

Tires/tubes

•

Footwear

•

Packing/shrink film

•

Asphalt modifier

•

Roofing

•

Adhesives

Increasingly strict regulations for tire performance:

•

Accelerates

technology

change

in

synthetic

rubber

production

from

Emulsion-

to

Solution-Styrene

Butadiene

Rubber

(SBR)

processes

•

For meeting these new regulations, our organolithium compounds are the preferred tool for Solution-SBR

2014 Global Synthetic

Rubber Capacity

by

Type, kMT

(Total 19.0 mMT)

Est.  2017 Global Synthetic

Rubber Capacity

by

Type, kMT

(Total 22.0 mMT)

Global Market Growth (CAGR):

Total Synthetic Rubber:  5.1% (2023)

S-SBR: ~10 % (2018)

38

Albemarle is well-prepared with high quality lithium initiators and global logistics to

serve the growing demand at operating and future rubber plants

Key starting material in high-performance synthetic rubber and aligned with new tire specs

ESBR;

4748

SSBR;

1743

BR;

4774

IR; 921

EPDM; 1476

IIR; 1539

CR; 377

NBR; 793

SBC;

2550

ESBR;

4908

SSBR;

2566

BR;

5457

IR; 1025

EPDM; 2166

IIR; 1926

CR; 402

NBR; 856

SBC;

2660

Source: IISRP Worldwide Rubber Statistics 2014

Like Albemarle’s Polyolefin Catalysts, Lithium Organometallics for

Synthesis is a High-touch, Pipeline-driven Business 

39

* At product maturity; assumes 100% success

Polyolefin

Catalysts

& Components

Pharma API & AgChem

Synthesis

Application

Custom catalyst products for specialty

resin applications

Proven tools for multiple high-value

synthetic processes

Projected Market Growth Rate*

7 -

10%

4 -

6%

Typical Customer Project Sponsors

Senior polymer scientists and

engineers at plants and R&D

Senior synthesis chemists at plants

and R&D

% of Sales Team with PhDs

40%

55%

# Active Customer Projects

>70

>100

Pipeline Revenue Value*

~$90MM

~$25MM

Source: IMS Market Prognosis, September 2014

The Albemarle Lithium Organometallic Sites are Strategically Located

Close to Important End-markets

Langelsheim, DE:

Butyllithium

Lithium Specialties

Taichung, TW:

Butyllithium

Frankfurt, DE:

R&D

New Johnsonville, TN: 

Lithium Specialties

Li Organometallics

40

Additionally, Albemarle’s broader network of organometallics production and distribution capabilities

provide a competitive advantage

Al Organometallics

Only Producer with Al & Li Chemistry Portfolio Polymers

•

Overlapping polymer end-markets for synthetic rubber and elastomer

applications

•

Already enhancing customer relationships to drive new sales to

synthetic rubber producers, with impact in 2015

•

2016 commitments for sales synergies from major customers

Common Manufacturing and Logistics Creates Asset Synergies

•

Larger organometallics network enables immediate supply synergies

•

Rationalizing butyllithium capacity in Tennessee

•

Leveraging the portable tank fleet  across

the broader portfolio

•

Next phase: Additional opportunities to

optimize Li and Al Specialties production

Combining Lithium-based and Aluminum-based Organometallics

Gives Albemarle

a Unique, Advantaged Position in the Industry

41

The Albemarle Lithium Organometallics Business is in the Best Position

to Outpace the Competition in the Short and Long Term

•

Most extensive global manufacturing and sales presence in organometallics

•

Extensive pipeline of agriculture and pharma synthesis projects

•

Back-integrated, lowest-cost position due to Chilean lithium supply position

•

Global

24/7

customer

technical

service

coverage

–

leveraging

the

critical

mass

of

the

combined Albemarle organometallics franchise

•

Organometallic

chemistry

and

production

expertise

–

leveraging

investment

across

product families

42

Albemarle’s Global Position in

Lithium

John Mitchell

Vice President, Performance Materials

Leadership in Lithium due to Albemarle’s Unique Position

44

Leading Natural Resources

Extensive Derivative Capability

Strength of Supply Chain Reliability

Process Innovation Expertise

Low Cost Position

Leader in High Quality Diversified Natural Resources

Hard Rock Minerals

SQM

36%

Albemarle

34%

FMC

21%

Chinese &

Others

9%

Talison

78%

Chinese

21%

Others

1%

Brine

Talison

31%

Albemarle

20%

SQM

22%

FMC

13%

Chinese

13%

Others

1%

Source: SAI Report 2015, Internal Estimates

45

LCE Mined in 2014

160,000 MT

2014 Brine

LCE Production Share

2014 Spodumene

LCE Production Share

98kT

62kT

Natural Resource Position

Albemarle >35% Total

LCE’s Mined

Two World-class Lithium Brine Resources Operated by

Albemarle

Salar de Atacama, Chile

•

Largest active lithium brine

resource globally

•

Highest LiCl concentration

•

Highest evaporation rates

•

Favorable brine chemistry

Silver Peak, Nevada, U.S.A.

•

First operational brine resource

globally

•

Only U.S. operational lithium

brine source

•

Favorable brine chemistry

•

Established Infrastructure

46

Natural Resource Position

Two World-class Lithium Brine Resources in Development 

Magnolia, Arkansas U.S.A.

•

Unique to only Albemarle

•

By-product brine from bromine

operation

•

Ability to leverage infrastructure

•

No mining cost

•

By-product enhancements given

bromine derivations

47

Salares 7, Atacama Chile

•

Early stage exploration project

•

Part

of

Talison

joint

venture

•

Positive results for lithium and

potassium

Natural Resource Position

Two World-class

Hardrock Resources Globally Owned by

Albemarle

Greenbushes, Australia

•

Large

reserve

–

50

year

mine

life

•

Scale

advantage

–

largest

active

•

Best

ore

quality

globally:

2.8

–

3.3%

Li

2

O

•

Low iron content for TG market

•

CG grain size and quality is superior

Kings Mountain, NC, U.S.A.

•

Large reserve 380 kT LCE

•

Second best ore quality globally:

1.8 -

2.0% Li

2

O

•

Inactive mine since mid 1980’s

48

Natural Resource Position

Albemarle’s Brine Resources are Geographically Well-

positioned (Chile & USA)

Chile

Salar de Atacama

Albemarle

Best Brine Source Globally

Shared by Albemarle

US

Magnolia, AR

Albemarle

Source linked to

Bromine Plant

US

Silver Peak, NV

Albemarle

Low Concentration

Argentina

Salar de Hombre Muerto

Salar de Olaroz

•

Weather Risk

•

High Altitude Issue

•

Infrastructure Challenges

•

Country Risk

China

•

Various Salars Brine

Chemistry Issues

•

Weather Risk

•

Infrastructure Challenges

Source: USGS, Roskill, Internal

49

Natural Resource Position

Albemarle’s Hardrock

Mining Resources are

Geographically Well-positioned (Australia & USA)

US

North Carolina

Albemarle Mine

Currently Inactive

China

Various Small Mines

21% of Total Production

Australia

Greenbushes Mine

78% Total Production

Zimbabwe

Bikita Mine

1% Global Production

50

Natural Resource Position

Albemarle Resources –

High Concentration and Much More

51

•

Chemical composition

•

Hydrogeology

•

Climate

•

Infrastructure

•

Utility requirements

•

Environmental

•

Social responsibility

•

Mine scale

•

Reserve size

Natural Resource Position

Lithium Concentrate in Brine

Silver Peak

(ALB Li)

Atacama

(ALB Li & SQM)

ppm

2000

1600

1200

400

0

800

Li

2

O

Concentration

in

Hardrock

2.8% -

3.3%

1.8%

%

4.0

3.0

2.0

1.0

0.0

ALB

Kings Mt.

ALB

Greenbushes

Other Brine Sources

Other Rock Sources

Resource Size

Climate

Chemistry

Infrastructure / Location

Tailings Management

Country Risk

Fresh Water Intensity / Availability

Energy Intensity / Availability

Scale of Mine

Atacama, Chile

Argentina

Example:  Resource Competitiveness Assessment

52

Natural Resource Position

Lithium Resource Projects in Development

53

•

xx

Source: Company reports and press releases

Company

Project status

Albemarle 

Pilot Plant

Orocobre

(started 2007)

Li

2

CO

3

Market Production           

2015-2016

Lithium

Americas 

Pilot plant

Galaxy Resources 

Feasibility

ADY Resources

Feasibility

Rodinia

Feasibility

Critical Elements

Corporation

Exploration

RB Energy

Li

2

CO

3

Shut-down

Receivership

Nemaska

Post  Feasibility

Neometals (Reed

Resources)

Pilot

Western Lithium

Demo plant

Bacanora Minerals

Feasibility

Natural Resource Position

Lithium Resource Development is Not Easy and Takes Time

54

Exploration

Feasibility

Pilot

Design

Construction

Production

Simbol

Canada Lithium

Galaxy Mt Cattlin

Albemarle Magnolia

Lithium Americas

Bacanora Minerals

Western Lithium

Bankrupt

Bankrupt

Closed

Ready for plant design

Brine

Spodumene

Spodumene

Brine

Brine

Hectorite

Nemaska Lithium

Hectorite

Spodumene

Plant

Natural Resource Position

$120 million spent collectively

<$20 million in cash reserves combined

Main focus is fundraising

Ability to Produce Value-added Lithium Derivatives is Unmatched

55

Life-Science Products

Battery Products

Other Products

•

Ability to optimize Li derivatives

•

Providing lithium compounds

throughout all stages of the value chain

•

Over 800 different SKUs

Lithium

Metal

Lithium

Metal

LDA

LDA

LHS

LHS

Li-t-

Butoxide

Li-t-

Butoxide

Li-

Amide

Li-

Amide

Li-

Salicylate

Li-

Salicylate

Li-tri

(t-butoxy)-

alanate

Li-tri

(t-butoxy)-

alanate

Li-

Citrate

Li-

Citrate

Li-

Benzoate

Li-

Benzoate

Li-

Acetate

Li-

Acetate

Li-

Zeolite

Li-

Zeolite

Potash

Potash

Bischofite

Bischofite

Li-

Sulphate

Li-

Sulphate

Li-

Nitrate

Li-

Nitrate

Li-

Phosphate

Li-

Phosphate

Li-

Silicate

Li-

Silicate

Li-Tetra-

borate

Li-Tetra-

borate

Li-

Chromate

Li-

Chromate

Sabalith

Sabalith

Li-

Nitride

Li-

Nitride

Li-

Bromide

Li-

Bromide

Li-

Fluoride

Li-

Fluoride

Li-

Peroxide

Li-

Peroxide

CO2-

Absorption

Products

CO2-

Absorption

Products

Li-

Iodide

Li-

Iodide

Li-

Perchlorate

Li-

Perchlorate

LiBOB

LiBOB

Anodes

Anodes

Foils

Foils

Lithium

Chloride

Lithium

Chloride

Brines

Brines

Lithium

Carbonate

Lithium

Carbonate

Lithium

Hydroxide

Lithium

Hydroxide

Ores

(Spodumene)

Ores

(Spodumene)

Li-

Alanate

Li-

Alanate

Li-

Hydride

Li-

Hydride

Li-Acetylide

Li-Acetylide

Methyl-

lithium

Methyl-

lithium

Phenyl-

lithium

Phenyl-

lithium

Butyl-

lithium

Butyl-

lithium

Li-

Methoxide

Li-

Methoxide

Extensive Derivative Capability

Unmatched Vertical Integration from Natural Resource to Lithium Specialty

56

Albemarle

SQM

FMC

Tianqi

Ganfeng

Operating

Brine Resource

Operating

Hardrock Resource

Spodumene TG

Lithium Carbonate TG/BG

Lithium Hydroxide TG

Lithium Hydroxide BG

Lithium Chloride

Li Metal Bulk

Li Metal Battery

Products

Butyllithium

Specialty Organics

Specialty Lithium Salts

Extensive Derivative Capability

Source: Internal

Leading Process Innovation & Expertise

57

Brine

Battery Grade Lithium Carbonate

Expansion

•

Significant quality improvement

•

Significant yield advantage

Hard

Rock

Battery

Grade Lithium

Salts

•

Projected lower cost vs. carbonate route

•

Aligns resource strength to value-added derivative

•

Process technology improvements

Smackover

Brine

Lithium

Salts

•

Leverage existing mining

& chemical operations

•

Process

interdependency advantage

High Purity Lithium Metal Production

•

Lowest impurity profile

•

Optimization

of process interdependencies

Process Innovation Expertise

Lower Cost

Higher Quality

Most Reliable

Proven Lithium Engineering…Only Further Enhanced

58

2008

SQM

Expansion

12kT

TG

Li

2

CO

3

2012

Albemarle

5kT

BG LiOH

2014

Canada Li

20kT

Li

2

CO

3

2014

Galaxy Jiangsu

17kT

Li

2

CO

3

2015

Orocobre

17kT

Argentina Brine

2015

Albemarle

20kT

BG

Li

2

CO

3

2005

SQM

6kT

TG LiOH

Successful Projects

Projects in Start-up

Failed Projects

CLOSED

SOLD

CLOSED

Bankrupt

Process Innovation Expertise

Global Supply Chain Strength For Battery Markets

59

Salar de Atacama, Chile

LaNegra, Chile

Kings Mountain, NC, USA

Silver Peak, NV, USA

Langelsheim, Germany

Frankfurt, Germany

Greenbushes, Australia

Established Battery Growth Market

Tesla 35 GWh

LG

Foxconn

LG

Samsung

Panasonic

BYD

Global Technical Centers

Production Sites

Battery Plants

Supply Chain Reliability

Emerging Battery Growth Market

Manufacturing Excellence in Lithium for over 100 years

60

Our People…

Our Culture…

Our Execution Focus…

•

Safety above all

•

We care about the communities we work in

•

Low cost

•

High quality

•

Most reliable

•

The world’s lithium experts

Supply Chain Reliability

Cost Advantage Continues to be Extended

Li Carbonate Cost Curve 2020

Co-market cost leader:  Albemarle

Market cost leader: Albemarle

•

Best lithium resources globally

•

Superior derivative process technology

•

Scale & supply chain advantage

Why?

Cost Leader

Li Hydroxide Cost Curve 2020

Capacity

Capacity

61

Leadership in Lithium due to Albemarle’s Unique Position

62

Leading Natural Resources

•

Diverse, large and high quality natural resources

•

Geographically situated in low-risk environments with good infrastructure

•

Large scale for excellent economics

Extensive Derivative Capability

•

Broad value-added derivative portfolio

•

Strongest vertical position from resource to specialty

•

Ability to innovate with customers for next-generation lithium materials

Strength of Supply Chain Reliability

•

Unmatched global footprint and ability to serve growth markets

•

100 years of lithium manufacturing experience

Process Innovation

•

Deep and broad process technology expertise

•

Scale of expertise has grown with merger adding to continues improvement

•

Strong experience in successfully commercializing new projects

A Low Cost Position

•

While providing the highest quality products

•

With the lithium industry’s most reliable and sustainable supply network

63

Albemarle Lithium Core Strengths Translated to Value

•

Natural Resource Management

•

Process Innovation

•

Project Execution Experience

•

Supply Chain Strength

•

Manufacturing Excellence

•

Our Team

Strengths

Strengths

•

Cost Leadership

•

Premium Quality Products

•

Security of Supply

•

Long-term Sustainable Partnership

•

Ability to Innovate

(Resources and Capability)

»

Advanced Materials for

Batteries

»

Organometallics and

Catalyst for Synthesis

Value

Value

Closing

Core Messages

65

1

Albemarle is the leader in lithium, one of the highest growth markets in the

specialty chemicals industry

2

Our unique

natural resource position, derivatization capabilities and

technology leadership allow Albemarle to execute its growth strategy

3

We can sustain the Albemarle advantage because our unique position is

difficult to replicate  and has taken more than 100 years to establish

•

World class Health, Safety & Environmental performance

•

Double-digit earnings growth

•

Maintain historical EBITDA  margin

•

Results-oriented, people-focused organization

•

Continued leadership positions in incumbent markets with market share

expansion in Energy Storage

Our Expectations

66

MT

Appendix

Non-GAAP Reconciliations

Non-GAAP Financial Measures

It

should

be

noted

that

adjusted

net

income

attributable

to

Albemarle

Corporation

(“adjusted

earnings”),

adjusted

diluted

earnings

per

share,

adjusted

effective

income

tax

rates,

segment

operating

profit,

segment

income,

EBITDA,

adjusted

EBITDA,

adjusted

EBITDA

by

operating

segment,

EBITDA

margin

and

adjusted

EBITDA

margin

are

financial

measures

that

are

not

required

by,

or

presented

in

accordance

with,

accounting

principles

generally

accepted

in

the

United

States,

or

GAAP.

These

measures

are

presented

here

to

provide

additional

useful

measurements

to

review

our

operations,

provide

transparency

to

investors

and

enable

period-to-period

comparability

of

financial

performance.

A

description

of

these

and

other

non-GAAP

financial

measures

that

we

use

to

evaluate

our

operations

and

financial

performance,

and

reconciliation

of

these

non-GAAP

financial

measures

to

the

most

directly

comparable

financial

measures

calculated

and

reported

in

accordance

with

GAAP,

can

be

found

herein.

68

Net Income and EBITDA

69

($ in thousands)

See above for a reconciliation of adjusted net income attributable to Albemarle Corporation (“adjusted earnings”), EBITDA and adjusted EBITDA, the non-GAAP

financial measures, to Net income attributable to Albemarle Corporation, the most directly comparable financial measure calculated and reported in accordance

with GAAP.  Adjusted net income attributable to Albemarle Corporation is defined as Net income attributable to Albemarle Corporation before discontinued

operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as Net income attributable to Albemarle Corporation

before interest and financing expenses, income taxes, depreciation and amortization.  Adjusted EBITDA is defined as EBITDA before discontinued operations

and the special and non-operating pension and OPEB items as listed below.

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Net income attributable to Albemarle Corporation

$

52,147

$

22,447

$

95,262

$

79,030

Add back:

Non-operating pension and OPEB items (net of tax)

(862)

(855)

(3,089)

8,089

Special items (net of tax)

43,807

5,189

130,123

16,334

Loss from discontinued operations (net of tax)

—

60,025

—

61,794

Adjusted net income attributable to Albemarle Corporation

$

95,092

$

86,806

$

222,296

$

165,247

Net income attributable to Albemarle Corporation

$

52,147

$

22,447

$

95,262

$

79,030

Add back:

Interest and financing expenses

33,182

8,733

68,928

17,506

Income tax expense (from continuing and discontinued operations)

17,139

1,624

31,279

14,070

Depreciation and amortization

67,483

24,905

131,469

52,714

EBITDA

169,951

57,709

326,938

163,320

Non-operating pension and OPEB items

(1,314)

(1,370)

(4,823)

12,701

Special items (excluding special items associated with interest

expense)

61,444

8,175

173,594

25,175

Loss from discontinued operations

—

80,174

—

82,687

Less depreciation and amortization from discontinued operations

—

—

—

(3,165)

Adjusted EBITDA

$

230,081

$

144,688

$

495,709

$

280,718

Net sales

$

931,485

$

604,721

$

1,815,889

$

1,204,564

EBITDA margin

18.2%

9.5%

18.0%

13.6%

Adjusted EBITDA margin

24.7%

23.9%

27.3%

23.3%

EBITDA Supplemental

70

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable

to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before interest and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations and the special and non-operating pension and OPEB items as listed above.

Performance

Chemicals

Refining

Solutions

Chemetall

Surface

Treatment

All Other

Corporate

Total

Three months ended June 30, 2015 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

83,016

39,717

26,254

$

3,612

(100,452

$

52,147

Depreciation and amortization

31,843

8,483

19,111

5,724

2,322

67,483

Special

items

(excluding

special

items

associated

with

interest expense)

33,823

—

3,077

378

24,166

61,444

Interest and financing expenses

—

—

—

—

33,182

33,182

Income tax expense

—

—

—

—

17,139

17,139

Non-operating pension and OPEB items

—

—

—

—

(1,314

(1,314)

Adjusted EBITDA

$

148,682

48,200

48,442

$

9,714

(24,957

$

230,081

Three months ended June 30, 2014 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

63,861

58,703

—

$

18,393

(118,510

$

22,447

Depreciation and amortization

13,093

7,848

—

3,423

541

24,905

Special items

—

—

—

—

8,175

8,175

Interest and financing expenses

—

—

—

—

8,733

8,733

Income tax expense

—

—

—

—

21,773

21,773

Loss from discontinued operations (net of tax)

—

—

—

—

60,025

60,025

Non-operating pension and OPEB items

—

—

—

—

(1,370

(1,370)

Adjusted EBITDA

$

76,954

66,551

—

$

21,816

(20,633

$

144,688

EBITDA Supplemental

71

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable

to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before

interest

and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations

and

the

special

and

non-operating

pension

and

OPEB

items

as

listed

above.

Performance

Chemicals

Refining

Solutions

Chemetall

Surface

Treatment

All Other

Corporate

Total

Three months ended June 30, 2014 (Pro forma):

Net income (loss) attributable to Albemarle Corporation

94,304

58,703

41,193

$

24,253

(149,269

$

69,184

Depreciation and amortization

25,149

7,848

7,879

4,373

5,513

50,762

Special items

—

—

—

—

7,907

7,907

Interest and financing expenses

—

—

—

—

22,333

22,333

Income tax expense

—

—

—

—

34,073

34,073

Loss from discontinued operations (net of tax)

—

—

—

—

47,425

47,425

Non-operating pension and OPEB items

—

—

—

—

(1,332

(1,332)

Adjusted EBITDA

119,453

66,551

49,072

$

28,626

(33,350

$

230,352

EBITDA Supplemental

72

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before

interest

and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations

and

the

special

and

non-operating

pension

and

OPEB

items

as

listed

above.

Performance

Chemicals

Refining

Solutions

Chemetall

Surface

Treatment

All Other

Corporate

Total

Six months ended June 30, 2015 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

154,679

73,800

37,109

9,027

(179,353)

95,262

Depreciation and amortization

62,126

16,593

37,307

11,222

4,221

131,469

Special

items

(excluding

special

items

associated

with

interest expense)

62,405

—

20,030

3,029

88,130

173,594

Interest and financing expenses

—

—

—

—

68,928

68,928

Income tax expense

—

—

—

—

31,279

31,279

Non-operating pension and OPEB items

—

—

—

—

(4,823)

(4,823)

Adjusted EBITDA

$

279,210

90,393

94,446

23,278

8,382

495,709

Six months ended June 30, 2014 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

125,190

111,057

—

35,724

(192,941)

79,030

Depreciation and amortization

25,149

16,528

—

6,787

1,085

49,549

Special items

—

—

—

—

25,175

25,175

Interest and financing expenses

—

—

—

—

17,506

17,506

Income tax expense

—

—

—

—

34,963

34,963

Loss from discontinued operations (net of tax)

—

—

—

—

61,794

61,794

Non-operating pension and OPEB items

—

—

—

—

12,701

12,701

Adjusted EBITDA

$

150,339

127,585

—

42,511

(39,717)

280,718

EBITDA Supplemental

73

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable

to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before

interest

and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations and the special and non-operating pension and OPEB items as listed above.

Performance

Chemicals

Refining

Solutions

Chemetall

Surface

Treatment

All Other

Corporate

Total

Six months ended June 30, 2014 (Pro forma):

Net income (loss) attributable to Albemarle Corporation

185,907

$

111,057

$

79,917

47,557

$

(319,517)

104,921

Depreciation and amortization

48,732

16,528

15,599

8,681

11,068

100,608

Special items

—

—

—

—

31,377

31,377

Interest and financing expenses

—

—

—

—

45,306

45,306

Income tax expense

—

—

—

—

60,063

60,063

Loss from discontinued operations (net of tax)

—

—

—

—

91,694

91,694

Non-operating pension and OPEB items

—

—

—

—

12,733

12,733

Adjusted EBITDA

234,639

$

127,585

$

95,516

56,238

$

(67,276)

446,702

EBITDA Supplemental

74

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable

to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before

interest

and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations and the special and non-operating pension and OPEB items as listed above.

Bromine

Lithium

PCS

Total

Performance

Chemicals

Three months ended June 30, 2015 (Actual):

Net income (loss) attributable to Albemarle Corporation

60,486

$

(213)

$

22,743

$

83,016

Depreciation and amortization

8,211

20,035

3,597

31,843

Special items

—

33,823

—

33,823

Adjusted EBITDA

68,697

$

53,645

$

26,340

$

148,682

Three months ended June 30, 2014 (Actual):

Net income (loss) attributable to Albemarle Corporation

43,623

$

—

$

20,238

$

63,861

Depreciation and amortization

8,907

—

4,186

13,093

Adjusted EBITDA

52,530

$

—

$

24,424

$

76,954

Three months ended June 30, 2014 (Pro Forma):

Net income (loss) attributable to Albemarle Corporation

43,623

$

30,443

$

20,238

$

94,304

Depreciation and amortization

8,907

12,056

4,186

25,149

Adjusted EBITDA

52,530

$

42,499

$

24,424

$

119,453

EBITDA Supplemental

75

($ in thousands)

See above for a reconciliation of adjusted EBITDA on a segment basis, the non-GAAP financial measure, to net income attributable

to Albemarle Corporation

(“earnings”), the most directly comparable financial measure calculated and reporting in accordance with GAAP.  Adjusted earnings on a segment basis is

defined as earnings before discontinued operations and the special and non-operating pension and OPEB items as listed above. EBITDA is defined as earnings

before

interest

and

financing

expenses,

income

taxes,

and

depreciation

and

amortization.

Adjusted

EBITDA

is

defined

as

EBITDA

before

discontinued

operations and the special and non-operating pension and OPEB items as listed above.

Bromine

Lithium

PCS

Total

Performance

Chemicals

Six months ended June 30, 2015 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

104,958

$

3,715

$

46,006

154,679

Depreciation and amortization

16,672

38,103

7,351

62,126

Special items

—

62,405

—

62,405

Adjusted EBITDA

$

121,630

$

104,223

$

53,357

279,210

Six months ended June 30, 2014 (Actual):

Net income (loss) attributable to Albemarle Corporation

$

91,657

$

—

$

33,533

125,190

Depreciation and amortization

17,590

—

7,559

25,149

Adjusted EBITDA

$

109,247

$

—

$

41,092

150,339

Six months ended June 30, 2014 (Pro Forma):

Net income (loss) attributable to Albemarle Corporation

$

91,657

$

60,717

$

33,533

185,907

Depreciation and amortization

17,590

23,583

7,559

48,732

Adjusted EBITDA

$

109,247

$

84,300

$

41,092

234,639

EBITDA Supplemental

76

1

This supplemental is for net-debt-to-adjusted EBITDA ratio based on the bank covenant

definition.

Twelve Months

Ended

Three Months Ended

30-Jun-15

30-Jun-15

March 31, 2015

December 31, 2014

September 30, 2014

Adjusted EBITDA

957,409

230,081

265,628

225,500

236,200

Net income attributable to to noncontrolling interests

24,259

7,219

4,034

4,460

8,546

Equity in net income of unconsolidated investments (net of tax)

(63,359)

(15,794)

(18,244)

(15,577)

(13,744)

Dividends received from unconsolidated investments

111,191

42,478

3,048

39,328

26,337

Runrate

synergies adjustment

28,909

28,909

-

-

-

Consolidated EBITDA

1,058,409

292,893

254,466

253,711

257,339

Total Long Term Debt

3,990,308

Off balance sheet obligations and other

57,666

Attributable principal amount of capital leases and synthetic leases

21,861

Consolidated Funded Debt

4,069,835

Less Cash

207,238

Consolidated Funded Net Debt

3,862,597

Consolidated Funded Net Debt to Consolidated EBITDA Ratio

3.6

Diluted EPS

77

1

Totals may not add due to rounding

Three Months Ended

Six Months Ended

June 30,

June 30,

2015

2014

2015

2014

Diluted earnings per share

$

0.46

$

0.28

$

0.86

$

0.99

Non-operating pension and OPEB items

(0.01)

(0.01

)

(0.03

)

0.10

Special items

0.39

0.07

1.18

0.21

Discontinued operations

—

0.76

—

0.78

Adjusted

Diluted

earnings

per

share

$

0.84

$

1.10

$

2.01

$

2.08

1

Equity Income and Minority Interest

Q1

Q2

Equity

Minority

Equity

Minority

Income

Interest

Income

Interest

Performance Chemicals*

1,765

(4,034)

(625)

(7,219)

Refining Solutions

5,012

-

3,658

-

Chemetall

1,291

-

650

-

All Other

2,324

-

2,111

-

Corporate

-

-

-

-

10,392

(4,034)

5,794

(7,219)

* Includes Inventory Step-Up

PC -

As Reported Equity Income

1,765

(625)

Inventory Step-Up

7,851

10,000

PC -

As Adjusted Equity Income

9,616

9,375

As Reported Equity Income

10,392

5,794

Inventory Step-Up

7,851

10,000

As Adjusted Equity Income

18,243

15,794

78

79

www.albemarle.com